HilleVax, Inc.
HLVXDelisted Sep 17, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001888012
HilleVax, Inc. was delisted on Sep 17, 2025; its insiders filed their last Form 4 on Sep 19, 2025; 74 institutions reported holding it in 13F filings for Q2 2025, worth $82.5M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in HilleVax, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- −6 vs. Q1 2023
- Shares held
- 25.4M
- −992.8K (−3.8%) vs. Q1 2023
- Total value
- $436.6M
- +$579.7K (+0.1%) vs. Q1 2023
- New holders
- 5
- 29 more added
- Sold out
- 11
- 9 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HLVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 74 | $82.5M |
| Q1 2025 | 81 | $61.1M |
| Q4 2024 | 76 | $88.7M |
| Q3 2024 | 79 | $73.5M |
| Q2 2024 | 94 | $657.8M |
| Q1 2024 | 81 | $730.0M |
| Q4 2023 | 69 | $678.3M |
| Q3 2023 | 68 | $459.3M |
| Q2 2023 | 54 | $436.6M |
| Q1 2023 | 61 | $436.2M |
| Q4 2022 | 55 | $440.2M |
| Q3 2022 | 51 | $399.9M |
| Q2 2022 | 57 | $253.7M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding HilleVax, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 9,781,472 | $168.1M | 10.04% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 3,329,231 | $57.2M | 1.22% | +495,541+17.5% | Added |
| Carlyle Group Inc. | 1,838,486 | $31.5M | 1.12% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 1,424,935 | $24.5M | 0.02% | +213,443+17.6% | Added |
| Franklin Resources Inc | 1,284,550 | $22.1M | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 1,270,472 | $21.8M | 0.00% | +232,625+22.4% | Added |
| Braidwell LP | 1,249,246 | $21.5M | 0.70% | −370,970−22.9% | Reduced |
| Vanguard Group Inc | 903,667 | $15.5M | 0.00% | +412,033+83.8% | Added |
| StepStone Group LP | 676,569 | $11.6M | 2.15% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 599,274 | $10.3M | 1.81% | −10,588−1.7% | Reduced |
| Morgan Stanley | 592,130 | $10.2M | 0.00% | −3,344−0.6% | Reduced |
| Qiming U.S. Ventures Management, LLC | 558,923 | $9.61M | 10.10% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 357,322 | $6.14M | 0.00% | +70,046+24.4% | Added |
| State Street Corp | 353,748 | $6.08M | 0.00% | +80,711+29.6% | Added |
| Northern Trust Corp | 161,131 | $2.77M | 0.00% | +28,116+21.1% | Added |
| Ensign Peak Advisors, Inc | 117,746 | $2.02M | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 112,140 | $1.93M | 0.00% | +9,299+9.0% | Added |
| Deutsche Bank AG | 108,974 | $1.87M | 0.00% | +98,198+911.3% | Added |
| Fred Alger Management, LLC | 87,043 | $1.50M | 0.01% | 00.0% | Unchanged |
| UBS Oconnor LLC | 80,478 | $1.38M | 0.03% | −789−1.0% | Reduced |
| Acuta Capital Partners, LLC | 63,078 | $1.08M | 0.73% | +56,414+846.5% | Added |
| Bank of New York Mellon Corp | 62,433 | $1.07M | 0.00% | +14,378+29.9% | Added |
| Nuveen Asset Management, LLC | 39,968 | $687.0K | 0.00% | +16,066+67.2% | Added |
| Goldman Sachs Group Inc | 30,818 | $529.8K | 0.00% | +15,853+105.9% | Added |
| Alps Advisors Inc | 28,812 | $495.3K | 0.00% | +6,839+31.1% | Added |
| Tekla Capital Management LLC | 27,000 | $464.1K | 0.02% | +27,000 | New |
| Rhumbline Advisers | 26,576 | $456.8K | 0.00% | +3,570+15.5% | Added |
| Swiss National Bank | 21,200 | $364.4K | 0.00% | 00.0% | Unchanged |
| TD Asset Management Inc | 18,528 | $318.5K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 18,390 | $316.1K | 0.00% | +4,650+33.8% | Added |
| Tudor Investment Corp Et Al | 17,724 | $304.7K | 0.00% | +17,724 | New |
| JPMorgan Chase & Co | 17,719 | $304.6K | 0.00% | +2,810+18.8% | Added |
| California State Teachers Retirement System | 15,693 | $269.8K | 0.00% | +611+4.1% | Added |
| UBS Group AG | 15,266 | $262.4K | 0.00% | +7,248+90.4% | Added |
| Martingale Asset Management L P | 12,279 | $211.1K | 0.00% | +12,279 | New |
| Alliancebernstein L.P. | 12,150 | $208.9K | 0.00% | +12,150 | New |
| MetLife Investment Management | 11,565 | $198.8K | 0.00% | +2,860+32.9% | Added |
| Credit Suisse AG | 11,173 | $192.1K | 0.00% | +11,173 | New |
| American International Group, Inc. | 10,216 | $175.6K | 0.00% | +1,791+21.3% | Added |
| Legal & General Group Plc | 10,161 | $174.7K | 0.00% | +5,047+98.7% | Added |
| New York State Common Retirement Fund | 9,713 | $167.0K | 0.00% | −2,785−22.3% | Reduced |
| Wells Fargo & Company | 8,205 | $141.0K | 0.00% | +5,084+162.9% | Added |
| Citigroup Inc | 7,234 | $124.4K | 0.00% | +6,608+1,055.6% | Added |
| Barclays PLC | 5,999 | $103.1K | 0.00% | −2,869−32.4% | Reduced |
| Royal Bank of Canada | 4,779 | $82.0K | 0.00% | +1,072+28.9% | Added |
| Tower Research Capital LLC (TRC) | 2,388 | $41.0K | 0.00% | −199−7.7% | Reduced |
| Amalgamated Bank | 2,189 | $38.0K | 0.00% | +220+11.2% | Added |
| Ameritas Investment Partners, Inc. | 1,753 | $30.1K | 0.00% | +781+80.3% | Added |
| Russell Investments Group, Ltd. | 1,572 | $27.0K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,198 | $20.6K | 0.00% | +287+31.5% | Added |
| Federated Hermes, Inc. | 1,170 | $20.1K | 0.00% | −1,025−46.7% | Reduced |
| China Universal Asset Management Co., Ltd. | 514 | $8.84K | 0.00% | +62+13.7% | Added |
| FMR LLC | 335 | $5.76K | 0.00% | −172−33.9% | Reduced |
| Daiwa Securities Group Inc. | 134 | $2.00K | 0.00% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,760,019−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −406,024−100.0% | Sold out |
| BVF Inc | 0 | $0 | 0.00% | −248,579−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,026−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,539−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −10,333−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −9,804−100.0% | Sold out |
| Sandia Investment Management LP | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −203−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −122−100.0% | Sold out |
| ETF Managers Group, LLC | – | – | – | – | Not filed |